Samrat Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE103E01016
  • NSEID:
  • BSEID: 530125
INR
223.30
7.05 (3.26%)
BSENSE

Nov 20

BSE+NSE Vol: 387

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 116063,
    "name": "Samrat Pharma",
    "stock_name": "Samrat Pharma",
    "full_name": "Samrat Pharmachem Ltd",
    "name_url": "stocks-analysis/samrat-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "223.30",
    "chg": 7.05,
    "chgp": "3.26%",
    "dir": 1,
    "prev_price": "216.25",
    "mcapval": "67.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 530125,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE103E01016",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "387 ",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/samrat-pharma-116063-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Samrat Pharmachem Ltd is Rated Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/samrat-pharmachem-ltd-is-rated-sell-4238785",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/SamratPharmache_mojoScore_4238785.png",
        "date": "2026-10-26 10:10:02",
        "description": "Samrat Pharmachem Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 October 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 October 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Samrat Pharmachem Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/samrat-pharmachem-ltd-upgraded-to-sell-on-technical-improvements-despite-weak-fundamentals-4226097",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/SamratPharmache_mojoScore_4226097.png",
        "date": "2026-10-15 08:06:48",
        "description": "Samrat Pharmachem Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 14 Oct 2026, driven primarily by a shift in technical indicators despite persistent fundamental weaknesses. The company’s micro-cap status and challenging financial trends continue to weigh on its outlook, but recent technical signals suggest a cautiously improved market sentiment."
      },
      {
        "title": "Samrat Pharmachem Ltd Downgraded to Strong Sell Amid Weak Fundamentals and Technical Setbacks",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/samrat-pharmachem-ltd-downgraded-to-strong-sell-amid-weak-fundamentals-and-technical-setbacks-4222285",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/SamratPharmache_mojoScore_4222285.png",
        "date": "2026-10-12 08:03:49",
        "description": "Samrat Pharmachem Ltd has been downgraded from a Sell to a Strong Sell rating as of 09 Oct 2026, reflecting deteriorating technical indicators and weak fundamental performance. The pharmaceutical micro-cap’s Mojo Score has declined to 23.0, signalling heightened risk for investors amid flat financial results and a challenging market environment."
      },
      {
        "title": "Samrat Pharmachem Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/samrat-pharmachem-ltd-is-rated-strong-sell-4221753",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/SamratPharmache_mojoScore_4221753.png",
        "date": "2026-10-11 10:10:27",
        "description": "Samrat Pharmachem Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 09 October 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 October 2026, providing investors with the most up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Samrat Pharmachem Ltd Upgraded to Sell: A Detailed Analysis of the Rating Change",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/samrat-pharmachem-ltd-upgraded-to-sell-a-detailed-analysis-of-the-rating-change-4209222",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/SamratPharmache_mojoScore_4209222.png",
        "date": "2026-09-30 08:08:49",
        "description": "Samrat Pharmachem Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 29 Sep 2026, driven primarily by a shift in technical indicators despite persistent fundamental weaknesses. The micro-cap pharmaceutical company’s recent performance and valuation metrics continue to raise concerns, but improved technical trends have prompted a more favourable outlook from analysts."
      },
      {
        "title": "Samrat Pharmachem Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/samrat-pharmachem-ltd-is-rated-strong-sell-4204852",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/SamratPharmache_mojoScore_4204852.png",
        "date": "2026-09-25 10:10:21",
        "description": "Samrat Pharmachem Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 07 September 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 25 September 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Samrat Pharmachem Ltd is Rated Sell by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/samrat-pharmachem-ltd-is-rated-sell-by-marketsmojo-4182345",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/SamratPharmache_mojoScore_4182345.png",
        "date": "2026-09-04 10:11:07",
        "description": "Samrat Pharmachem Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 Aug 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 September 2026, providing investors with the latest insights into the company’s performance and outlook."
      }
    ],
    "total": 31,
    "sid": "116063",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/samrat-pharmachem-116063"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "18-Nov-2026",
      "details": "Newspaper Publication of extract of Standalone Unaudited Financial Results for the quarter ended 30th September 2026",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 14Th November 2026",
      "datetime": "14-Nov-2026",
      "details": "The Board of Directors considered and adopted the unaudited financial results for the quarter ended September 30 2026",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "13-Oct-2026",
      "details": "Certificate under Reg. 74(5) of SEBI (DP) Regulations for the quarter ended 30th September 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Samrat Pharmachem Ltd has declared <strong>10%</strong> dividend, ex-date: 18 Sep 25",
          "dt": "2025-09-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Newspaper Publication

18-Nov-2026 | Source : BSE

Newspaper Publication of extract of Standalone Unaudited Financial Results for the quarter ended 30th September 2026

Board Meeting Outcome for Outcome Of Board Meeting Held On 14Th November 2026

14-Nov-2026 | Source : BSE

The Board of Directors considered and adopted the unaudited financial results for the quarter ended September 30 2026

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

13-Oct-2026 | Source : BSE

Certificate under Reg. 74(5) of SEBI (DP) Regulations for the quarter ended 30th September 2026.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Samrat Pharmachem Ltd has declared 10% dividend, ex-date: 18 Sep 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available